No products in the cart.
Description
Medicube Zero Pore Serum is a high-concentration exfoliating serum with 15.2% AHA, BHA and PHA plus 2% niacinamide. It is designed to refine skin texture, reduce the appearance of pores, and support a smoother, more even-looking complexion.
This serum combines chemical exfoliants with niacinamide to help manage sebum, improve skin texture, and brighten the look of dull or uneven skin. The formula is suitable for those looking for pore care and exfoliation in one step.
Benefits
- High-concentration exfoliating serum with 15.2% AHA, BHA and PHA
- Contains 2% niacinamide for pore and sebum care
- Helps refine skin texture
- Reduces the appearance of pores
- Supports a smoother, more even-looking complexion
How to use
After cleansing and toning, apply a moderate amount to the face. Gently pat into the skin. Use as part of your evening skincare routine. Always follow with SPF during the day when using exfoliating products.
Key features
- 15.2% AHA, BHA, PHA complex
- 2% niacinamide
- Exfoliating pore serum
- For smoother, refined skin texture
Frequently Asked Questions
What does this serum do?
It exfoliates the skin with AHA, BHA and PHA while niacinamide helps with pore and sebum care.
What is the exfoliating concentration?
It contains 15.2% combined AHA, BHA and PHA.
When should I use it?
Use in your evening routine. Always use SPF during the day when using exfoliating products.
Does it contain niacinamide?
Yes, it contains 2% niacinamide.
Be the first to review “Medicube Zero Pore One Day Serum”
Delivery
We aim to pick, pack and ship all orders within 24 hours. However, in some cases, such as weekends or periods of high order volume, there may be a delay in shipping times.
Returns
If you are unhappy with your purchase, we will exchange the item or issue a credit note, provided the goods are not damaged, all original packaging remains intact and the item is returned within 28 days of purchase.
This policy does not affect your statutory rights.







Reviews
There are no reviews yet.